Gastrointestinal (GI): NSAIDs that block COX-one action have correlations with GI issues as a result of inhibition of the synthesis of gastroprotective brokers including PGE2 along with other prostaglandins. This inhibition leads to diminished mucin creation by gastric epithelial cells, much less bicarbonate secretion, and fewer epithelial cell turnover, between https://rafaelarzxz.ampedpages.com/diclofenac-sodium-an-overview-57390678